Ultra-hypofractionated radiation therapy for unfavourable intermediate-risk and high-risk prostate cancer is safe and effective: 5-year outcomes of a phase II trial

  1. Macias, V.A.
  2. Barrera-Mellado, I.
Aldizkaria:
BJU International

ISSN: 1464-410X,  1464-4096

Argitalpen urtea: 2020

Alea: 125

Zenbakia: 2

Orrialdeak: 215-225

Mota: Artikulua

DOI: 10.1111/BJU.14925 GOOGLE SCHOLAR lock_openSarbide irekia editor
Datuen iturria: Scopus